Related Experiment Video
Updated: Mar 6, 2026

Identification of Sleeping Beauty Transposon Insertions in Solid Tumors using Linker-mediated PCR
Published on: February 1, 2013
A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes
Jorge de la Rosa1,2,3, Julia Weber4,5, Mathias Josef Friedrich1
1The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Abstract:
The overwhelming number of genetic alterations identified through cancer genome sequencing requires complementary approaches to interpret their significance and interactions. Here we developed a novel whole-body insertional mutagenesis screen in mice, which was designed for the discovery of Pten-cooperating tumor suppressors. Toward this aim, we coupled mobilization of a single-copy inactivating Sleeping Beauty transposon to Pten disruption within the same genome. The analysis of 278 transposition-induced prostate, breast and skin tumors detected tissue-specific and shared data sets of known and candidate genes involved in cancer. We validated ZBTB20, CELF2, PARD3, AKAP13 and WAC, which were identified by our screens in multiple cancer types, as new tumor suppressor genes in prostate cancer. We demonstrated their synergy with PTEN in preventing invasion in vitro and confirmed their clinical relevance. Further characterization of Wac in vivo showed obligate haploinsufficiency for this gene (which encodes an autophagy-regulating factor) in a Pten-deficient context. Our study identified complex PTEN-cooperating tumor suppressor networks in different cancer types, with potential clinical implications.
Insights
This study identifies new tumor suppressor genes that cooperate with PTEN to prevent cancer. These findings reveal complex tumor suppressor networks with potential clinical applications in various cancer types.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Cancer genome sequencing reveals numerous genetic alterations, necessitating methods to understand their functional significance.
- Identifying genes that cooperate with tumor suppressors like PTEN is crucial for understanding cancer development.
Purpose of the Study:
- To discover novel Pten-cooperating tumor suppressors using a whole-body insertional mutagenesis screen in mice.
- To identify and validate new tumor suppressor genes involved in prostate, breast, and skin cancers.
Main Methods:
- Developed a novel whole-body insertional mutagenesis screen in mice by coupling a Sleeping Beauty transposon to Pten disruption.
- Analyzed 278 transposition-induced tumors across multiple cancer types.
- Validated candidate genes through in vitro and in vivo experiments.
Main Results:
- Identified tissue-specific and shared gene sets involved in cancer, including ZBTB20, CELF2, PARD3, AKAP13, and WAC.
- Validated these genes as novel tumor suppressors cooperating with PTEN in prostate cancer, demonstrating synergy in preventing invasion.
- Showed obligate haploinsufficiency of Wac in a Pten-deficient context.
Conclusions:
- Discovered complex PTEN-cooperating tumor suppressor networks across different cancer types.
- Validated several novel tumor suppressor genes with potential clinical relevance.
- Highlighted the role of WAC in autophagy regulation within a Pten-deficient cancer context.
More Related Videos
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
In-vitro Mutagenesis